To further confirm that CD36 and CCL2 contribute to NASH progression in Mettl3-HKO mice, Mettl3-HKO mice were fed an MCD diet and treated with a combination of anti-CD36 and anti-CCL2-neutralizing antibodies. Here, METTL3 is linked to metabolic dysfunction-associated steatohepatitis.